Pharmaron Beijing Co., Ltd. (3759.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 31B |
| Enterprise Value | 33.4B |
| P/E Ratio | 38.33 |
| PEG Ratio | -4.47 |
| Price/Sales Ratio | 3.74 |
| Price/Book Ratio | 4.03 |
| Enterprise/Revenue | 4.07 |
| Enterprise/EBITDA | 18.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 14.1B |
| Revenue/Share | 8.05 |
| Gross Profit | 4.91B |
| EBITDA | 3.29B |
| Net Income | 1.66B |
| Diluted EPS | 0.94 |
Balance Sheet
| Total Cash | 2.97B |
| Total Cash/Share | 1.65 |
| Total Debt | 7.08B |
| Total Debt/Equity | 0.43 |
| Current Ratio | 1.08 |
| Book Value Per Share | 9.49 |
Price History
| 52-Week Change | 5.24 |
| 52-Week High | 30.12 |
| 52-Week Low | 14.45 |
| Moving Average 50 Days | 19.21 |
| Moving Average 200 Days | 20.71 |
Statistics
| Average Volume | 7.03M |
| Shares Outstanding | 2.73B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.54 |
| Payout Ratio | 0.32 |
| Last Split Factor | 3:2 |
| Last Split Date | July 18, 2023 |
AD
